<DOC>
	<DOCNO>NCT02863016</DOCNO>
	<brief_summary>The aim study evaluate effect time action inflammatory state acetate-free contain citrate concentrate ( Cit- , 1 mM Citrate ) online postidultion HDF high volume compare traditional concentrated ( Ac- , 3 mM acetate ) medium term . In addition , study evaluate parameter efficiency dialysis , cardiovascular stability , safety concentrate regard bone metabolism vessel calcification medium term .</brief_summary>
	<brief_title>Effects Postdilution Online Hemodiafiltration AcEtate-free Citrate dialySis Fluid Inflammation Markers TUscan Prevalent Hemodialysis patientS</brief_title>
	<detailed_description>The primary objective study evaluate hemodiafiltration concentrate citrate ( Cit-HDF ) 3 month reduce inflammation marker , evaluate Predialytic value Beta2-microglobulin ( B2m ) , CRP IL6 compare traditional concentrated acetic acid ( Ac-HDF ) . The secondary objective study evaluate Cit-HDF , compare Ac-HDF , effect period 3 month follow aspect : - change weekly pre-dialysis value marker oxidative stress ( TAC , NF-kB ) ; - technical parameter HDF treatment , convective volume , blood pressure circuit filter ( TMP , pressure pre-filter ) ; - cardiovascular stability blood pressure heart rate dialysis ( SBP , DBP , HR ) number intradialytic hypotension ; - parameter safety variation value mobility Predialytic bone ( PTH , alkaline phosphatase , fetuin-A ) , variation value intradialytic biochemical impact citrate ( total ionized calcium , bicarbonate ) clotting time ( aPTT ) ; - variation calcification observe : - expression molecule express ability calcification muscle cell endothelial cell culture plasma take begin treatment - measure carotid intimal thickness pulse vawe velocity Eco Color Doppler ( optional ) ; - dialysis efficiency vary pre-and post-dialysis ( RR % ) Clearance average molecular weight solutes small medium ( Phosphorus , Beta2 Micro , Myoglobin ) indices dialysis adequacy small molecule EKT / V base dialysance ion formula Watson ( calculate automatically monitor dialysis ) ;</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>. Patients clinically stable . age &gt; 18 . HDF renal replacement therapy 1 month . good functionality vascular blood flow allow real least 250 ml / min . recirculation 10 % . Life expectancy &lt; 3 month . With residual renal function &gt; 500 ml / day . Vascular access CVC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>dialysis</keyword>
	<keyword>hemodiafiltration</keyword>
</DOC>